Stock: RVTY. Includes companies and brands it has bought. Official US government data, updated September 2026.
510(k) clearances
24
De Novo: 3
PMA approvals
1
12 supplements
Recalled products
58
0 class I
Adverse event reports
92
1 deaths reported
Revvity has 58 recalled medical device products in 34 recall actions in the records, 0 of them class I (the most serious kind). The newest recall started on Jan 10, 2019. In 2018 it had 1 recalled products.
24 510(k) clearances, 3 De Novo grants and 1 original PMA approvals for high-risk devices, plus 12 PMA supplements (changes to approved devices). The newest decision was on Nov 9, 2022.
92 reports in total: 1 deaths, - injuries and 86 malfunctions were reported. 5 reports were received in 2021. A report alone does not show that the device caused the problem.
Last 15 years
| Year | 510(k) clearance | De Novo grant | PMA approval | PMA supplement |
|---|---|---|---|---|
| 2022 | 1 | 1 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 1 |
| 2020 | 1 | 0 | 0 | 0 |
| 2019 |
By product code, all years
All device makers and procedures · RVTY stock page
Official US government data on medical device marketing decisions, recalls (one row per recalled product) and adverse event reports. Company names in the records are linked to RVTY with a reviewed list that includes the companies it has bought. Adverse event reports come from makers, hospitals, doctors and patients; a report alone does not prove that a device caused the problem.
| 2 |
| 1 |
| 0 |
| 0 |
| 2018 | 2 | 0 | 0 | 1 |
| 2017 | 0 | 0 | 0 | 1 |
| 2016 | 2 | 0 | 0 | 1 |
| 2014 | 3 | 0 | 0 | 0 |
| 2013 | 1 | 0 | 0 | 0 |
| 2012 | 1 | 0 | 0 | 2 |
Recalled products, class I, and reports received
| Year | Recalls | Class I | Reports | Deaths |
|---|---|---|---|---|
| 2025 | 0 | 0 | 1 | - |
| 2021 | 0 | 0 | 5 | - |
| 2020 | 0 | 0 | 1 | - |
| 2017 | 10 | 0 | 48 | - |
| 2016 | 8 | 0 | 1 | - |
| 2015 | 14 | 0 | 29 | - |
| 2014 | 2 | 0 | 1 | - |
| 2013 | 0 | 0 | 1 | 1 |
| 2012 | 7 | 0 | 2 | - |